Shares of Novacyt S.A. (LON:NCYT – Get Free Report) traded down 8.7% during trading on Tuesday . The company traded as low as GBX 71.62 ($0.94) and last traded at GBX 74.22 ($0.97). 321,269 shares changed hands during mid-day trading, a decline of 49% from the average session volume of 631,196 shares. The stock had previously closed at GBX 81.30 ($1.06).
Novacyt Price Performance
The stock has a market cap of £52.82 million, a P/E ratio of -183.33 and a beta of -1.86. The company has a debt-to-equity ratio of 15.71, a current ratio of 2.92 and a quick ratio of 4.46. The business’s fifty day moving average price is GBX 63.85 and its 200 day moving average price is GBX 57.76.
Novacyt Company Profile
Novacyt SA, together with its subsidiaries, provides in vitro and molecular diagnostic tests for a range of infectious diseases in the United Kingdom, rest of Europe, the United States, the Asia Pacific, the Middle East, and Africa. It operates through Primer Design, Lab21 Products, and IT-IS International segments.
Featured Articles
- Five stocks we like better than Novacyt
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- What Is WallStreetBets and What Stocks Are They Targeting?
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- The How and Why of Investing in Gold Stocks
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
Receive News & Ratings for Novacyt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novacyt and related companies with MarketBeat.com's FREE daily email newsletter.
